In this guide
What is SNAP-8?
SNAP-8 is a lab-made peptide, a short chain of eight amino acids, sold as an anti-wrinkle skin-care ingredient. It is meant to soften expression lines, the creases that form where facial muscles move, such as forehead lines, frown lines and crow's feet. [1]
The name comes from SNAP-25, a protein that nerve cells need to release their chemical signals, plus the number of amino acids in the chain. Its ingredient-label name is acetyl octapeptide-3. The Spanish ingredient company Lipotec developed it, and its SNAP-8 products are now sold by Lubrizol. It was designed as a longer version of Lipotec's earlier peptide Argireline (acetyl hexapeptide-8): SNAP-8 is Argireline's six amino acids plus two more. [1], [2], [3], [4]
Older documents and databases also call it acetyl glutamyl heptapeptide-1 or -3, and one database lists "acetyl octapeptide 1" as a synonym. These names describe the same molecule; the current EU ingredient name is acetyl octapeptide-3. [1], [5], [4]
SNAP-8 is a cosmetic ingredient, not a medicine. Cosmetic makers buy it as a very dilute ready-made solution. Research-chemical sellers also sell it as a powder in small vials, and some of their pages add injection schedules, even though no study has tested injected SNAP-8. Every published human study so far used a cream, serum or skin patch that contained several active ingredients. This guide explains the strengths people use, what the studies actually found and what remains unknown. [2], [6], [7], [8]
Typical SNAP-8 Protocols
| Example | Solution in the product | SNAP-8 itself | How often | Duration |
|---|---|---|---|---|
| Starting trial | 3–5% | About 0.0015–0.0025% | Once or twice daily | 4 weeks, then judge the result |
| Supplier's tested schedule | 10% | About 0.005% | Twice daily | 28 days Applied around the eyes in the supplier's 17-woman test |
| Ongoing use | 3–10% | About 0.0015–0.005% | Twice daily | No end date given |
The most common protocol in the reviewed sources is a cream or serum containing 3–10% of the supplier's SNAP-8 solution (about 0.0015–0.005% SNAP-8 itself), applied twice daily, with results judged after about four weeks. [1], [11], [12], [13], [14]
- Titration Changing the strength in steps
- Most sources start at the chosen strength and keep it. One protocol page lists 3–5% of the solution for a four-week initial trial and, as a separate regimen rather than a titration step, 10% twice daily for ongoing use; another lists 1–3% for maintenance and 5–10% as an "intensive" level. [9], [13]
Read the units: the percentage on a supplier sheet is the share of its ready-made solution, not of pure SNAP-8. That solution contains about 0.05% SNAP-8, so 10% of it in a cream is about 0.005%, or 50 parts per million. By contrast, one 10 mg vial of powder dissolved in about 30 mL of serum is about 0.033%, roughly 7 times the supplier's top level. See how strong homemade serums are. [1], [2], [17]
Each row is a complete schedule as its source published it. The rows are alternatives, not steps to move through. These schedules come from the supplier's own test and protocol websites, not from controlled trials: no study has compared strengths or schedules of SNAP-8 on its own. The cited references give the full details. [1], [9], [10]
Before relying on any row: stronger is not proven better. No study has tested any strength above the supplier's level, and homemade serums often run dozens to thousands of times higher. In community education groups, the few reports of a stiff, "frozen" face and of one-sided sagging near the mouth came from very strong homemade mixes. Patch-test a new product on a small area first, and stop if one side of the face starts to droop. Homemade serums are not sterile, so using them with microneedling carries a risk of skin reactions called granulomas, which have been reported with other non-sterile serums. SNAP-8 has not been studied in pregnancy, breastfeeding, people under 18 or people with conditions that weaken muscles. Full risks ↓ [18], [19], [20], [21]
Where protocols differ: strengths, injection pages and blends ↓
Where these numbers come from
The starting-trial row comes from Peptide Initiative, which gives 3–5% of the supplied peptide solution once to twice daily as an initial four-week trial and, as a separate regimen that it says is not a titration schedule, 10% twice daily for ongoing use [9]. The supplier's tested schedule is Lipotec's own test: a cream containing 10% of its SNAP-8 solution, applied twice a day around the eyes of 17 women for 28 days [1]. The ongoing-use row comes from Peptide Mag: 3–10% solution twice daily, ongoing [10].
The summary sentence reflects the largest group of pages we compared: 19 of 37 dosing and supplier pages repeat the 3–10% use level, and most pages that give a frequency say twice daily or morning and evening, echoing the supplier's 28-day test [1], [11], [12], [22], [13], [14]. These pages copy the supplier sheet, so this is one origin repeated many times, not independent confirmation. Lubrizol's later test used 3% of the solution, the bottom of the range [3], [15].
We kept these out of the table: brand labels such as "10% SNAP-8" that do not say whether they mean the solution or pure peptide [23]; pages that treat 3–10% as pure powder, a unit error shown in the strength table below [18], [19]; and injection schedules, which have their own table [7], [24], [25].
What is SNAP-8 commonly used for?
Almost everyone who uses SNAP-8 wants the same thing: softer expression lines, especially on the forehead, between the brows and at the corners of the eyes. It is marketed, and often described online, as a gentler, needle-free relative of wrinkle-relaxing injections. [1], [26]
The research behind that hope is thin. All the human studies tested finished products that combined SNAP-8 with other active ingredients, so none can say what SNAP-8 contributed. What follows describes the hopes and the reports, with the evidence type for each. [27], [15], [28]
Forehead lines, frown lines and crow's feet
This is the main use, and the one the supplier tested. In its unpublished test, 17 women used a cream containing SNAP-8 around the eyes twice daily for 28 days, and wrinkle depth measured from skin impressions fell by about 35% on average. Product studies of multi-ingredient serums and patches also reported smoother lines over 4 to 24 weeks, mostly without a comparison group. The human research section explains what those numbers can and cannot show. [1], [15], [16], [28]
A "Botox alternative" or a way to stretch toxin treatments
Many people hope SNAP-8 can replace or extend botulinum toxin injections, the prescription treatment for frown lines. The supplier called it "a safer, cheaper, and milder alternative" to the toxin, but no study has compared them, and in the supplier's own laboratory test the toxin worked at a concentration about 2,000 times lower. In public forums, regular toxin users describe it as a way to keep lines softer between appointments, and some remain "on the fence"; in community education groups, most toxin users call it weaker. [1], [29], [30]
Smoother, more hydrated skin
Some people mainly notice that their skin feels smoother, plumper or more hydrated within days. The serums people use are often made with hyaluronic acid, a moisture-holding ingredient that does this on its own, so a quick change in skin feel says little about SNAP-8. [31], [32], [16]
With microneedling or skin patches
Some people apply SNAP-8 during microneedling, in which tiny needles make channels in the skin, hoping more of it gets in. Two human studies tested dissolving microneedle patches that contained SNAP-8 with other active ingredients. Neither measured how much SNAP-8 reached the skin, and using a non-sterile homemade serum during microneedling has its own risks, covered in the safety section. [33], [28], [20]
Other uses you may come across
Websites and sellers also mention acne, eyelash growth, pigmentation and whole-body "anti-aging" from injections. We found no study of SNAP-8 for acne or lashes. The one pigmentation report was a single man treated with a device that pushed a five-peptide serum into the skin. No study supports injecting SNAP-8 for any purpose. [34], [36]
See the human study results or explore the supporting laboratory research.
Where do SNAP-8 protocols differ?
On paper the supplier's instructions are simple. In practice, sources disagree about what the percentage means, how strong a homemade serum should be, how often to apply it, whether to use it with microneedling and whether to inject it at all. Here is what those differences mean when reading a protocol.
Is "10% SNAP-8" the solution or pure peptide?
This is the most important question, and the most common mistake. SNAP-8 reaches cosmetic makers as a ready-made solution containing about 0.05% SNAP-8, and the supplier's "3–10%" means 3–10% of that solution. Many pages and posters read it as 3–10% of pure powder, which is about 2,000 times more SNAP-8 than the same percentage of the solution. [1], [2], [18], [19]
How strong is a SNAP-8 serum?
Share of pure SNAP-8; icons use a scale where each step is ten times stronger. The shaded band is the supplier’s level; × compares with its top (0.005%).
- Supplier’s solution as sold
- about 0.05% (not a product strength)
- Finished product at 3–10% of that solution
- 0.0015–0.005% (the supplier’s level)
- Microneedle patch, 2024 study
- 0.03% · about 6× (share of a patch, not a cream)
- One 10 mg vial in about 30 mL of serum
- about 0.033% · about 7×
- One 100 mg jar in 1 ounce (about 30 mL)
- about 0.33% · about 67×
- 0.9–1.5 g of powder in 30 mL
- 3–5% · 600–1,000×
- 3 g of powder in 30 g
- 10% · about 2,000×
Pure SNAP-8 as a share of the product. Arithmetic from supplier documents and published recipes; no study has tested strengths above the supplier's level.
The supplier's level is 0.0015–0.005% SNAP-8; many homemade recipes are tens to thousands of times stronger.
| Recipe or product | SNAP-8 itself | Compared with the supplier's top level (0.005%) | Where it appears |
|---|---|---|---|
| 3–10% of the supplier's 0.05% solution | 0.0015–0.005% | Up to 1× | Supplier documents [1], [2] |
| One 10 mg vial in 200 g of cream | 0.005% | About 1× | A dosing page's calculation [37] |
| Dissolving microneedle patch in a 2024 study | 0.03% of the patch | About 6× (a patch, not a cream) | Human study [28] |
| One 10 mg vial in about 30 mL of serum | About 0.033% | About 7× | Dosing page and public forums [17], [38] |
| One 100 mg jar in 1 ounce (about 30 mL) of serum | About 0.33% | About 67× | Public forums [39], [40] |
| 0.9–1.5 g of powder in 30 mL | 3–5% | 600–1,000× | A seller's dosing page [18] |
| 3 g of powder in 27 g of base (30 g total) | 10% | About 2,000× | A seller's how-to page [19] |
In community education groups, the most common homemade recipe dissolves a 100 mg jar of powder in 1–2 ounces of hyaluronic-acid serum, roughly 0.17–0.33%, and one educator's own serum works out to about 5%. Members often call a 10 mg vial per ounce too weak, although it is already about 7 times the supplier's top level. Only a few members point out that the supplier's percentage refers to a solution.
No study shows that these higher strengths work better, and none has tested whether they are as well tolerated. Brand labels add to the confusion: a serum sold as "10% SNAP-8" or "20% acetyl octapeptide-3" rarely says whether it means the supplier's solution or pure peptide. [23], [31]
Once or twice a day, morning or night?
Twice daily, morning and evening, is the most common instruction, and it comes from the supplier's 28-day test. Some sources say once daily or "daily". A few people apply it only at night, reasoning that skin repairs overnight, while others argue that a muscle-relaxing effect matters most during the day, when faces move. No study has compared these schedules. [1], [9], [14], [41]
Do sources start low, or at full strength?
Most start at a fixed strength. One protocol page lists a 3–5% level for a four-week initial trial and a 10% level for ongoing use, but presents them as separate regimens, not a titration schedule. In community practice the pressure runs the other way: people who notice little often double the amount or switch from a vial to gram-scale powder, without any evidence that more helps. [9], [42]
How long before judging it, and are breaks needed?
The supplier judged its cream at 28 days, and the product studies ran 4 to 24 weeks. Protocol pages suggest assessing at 4–8 weeks. No source describes a planned break for topical use, and no study looked at what happens after a long course. [1], [16], [14]
With microneedling, or as a plain serum?
Some pages and community members apply SNAP-8 during or after microneedling. One guide suggests 5% "during and after" a session, and educators in community education groups advise sessions every one to two weeks with short needles. The only human data come from factory-made dissolving patches, which are different from pushing a homemade serum through a needling device. Case reports describe granulomas, stubborn lumps of inflamed tissue, after serums that were not made for injection were used with microneedling. [43], [28], [20], [21]
What do the injection schedules online say?
Some research-chemical and protocol pages publish injection schedules for SNAP-8 vials. These are shown separately because they have nothing behind them: no human or animal study has tested injected SNAP-8, and vials sold "for research use" are not made or tested as sterile injectables.
| Website schedule | Amount each time | Frequency | Total per day or session | Duration |
|---|---|---|---|---|
| Daily escalation | 330 mcg, then 500 mcg, then 1,000 mcg | Once daily, subcutaneous | 330, 500, then 1,000 mcg a day | Weeks 1–4, 5–8 and 9–12 (an 8–12-week cycle) |
| Facial sites | 50 mcg per site at 3–5 facial sites, then 100 mcg per site from week 5 | 1–2 times a week | About 150–500 mcg per session | 12 weeks, then 4–8 weeks off |
| Skin-procedure sessions | 2–5 mg per treatment | Every 7–10 days | 2–5 mg per session | 3–5 sessions Described as intradermal or mesotherapy use |
These are three different ideas, not one range. Other pages give yet more: 500 mcg to 2 mg every two to three days, 100–500 mcg per site weekly, or 0.1–0.5 mg per session, each without a study. One well-known dosing site carried the daily-escalation schedule until at least May 2026 and has since replaced it with a topical-only page stating that no injection study exists. [18], [10], [45], [17]
Where the daily-escalation numbers come from: a 10 mg vial mixed with 3 mL of liquid holds about 3.33 mg per mL. On a U-100 insulin syringe, 10 units (0.10 mL) then hold about 333 mcg, 15 units about 500 mcg and 30 units about 1,000 mcg, the three steps of the schedule. The numbers come from syringe markings, not from any test in people or animals. The same vial mixed with a different amount of liquid changes what each unit holds; Doserly's reconstitution calculator shows the arithmetic for any vial. [7], [8]
In public forums and community education groups, the prevailing view is that SNAP-8 belongs on the skin and should not be injected. A handful of people describe injecting vials, none with a clear result, and one person reported an improvement while describing an injection volume larger than the vial held. [46], [47], [48]
What about blends with GHK-Cu and KLOW?
Most homemade SNAP-8 serums also contain GHK-Cu, a copper peptide. Community recipes commonly mix a 100 mg jar of SNAP-8 with 300 mg of GHK-Cu in an ounce of hyaluronic-acid serum, or 20 mg of SNAP-8 with 1 g of GHK-Cu. A common forum claim that copper "inactivates" SNAP-8 has no test behind it either way. [39], [49], [40]
Some sellers now add SNAP-8 to injectable blends, such as a "KLOW plus SNAP-8" vial that combines it with the four KLOW peptides. In community education groups these blends cause real confusion: one educator's course said not to inject SNAP-8, while the same educator's advice for the blend was to use the usual KLOW amount if injecting it. No study has tested SNAP-8 in any blend, by any route.
Where do the sources disagree most?
- What the percentage means: 3–10% of a 0.05% solution, or 3–10% of pure powder. The second reading is about 2,000 times stronger. [2], [18]
- How strong a homemade serum should be: recipes run from 0.005% to 10% pure peptide. [37], [19]
- Frequency: twice daily, once daily or nightly. [1], [9]
- Route: skin only, or injection. Every study used the skin; injection schedules have no study. [15], [7]
- Citations: one professional-looking "clinical reference guide" cites journal articles that do not exist, and one protocol page lists an Argireline study as SNAP-8 research. [43], [7], [50]
Source-by-source comparison and registered study plans
Which pages publish complete schedules?
Unit key: percentages of the supplier's solution, not of pure SNAP-8, unless stated; 1 mg = 1,000 mcg.
- Lipotec (supplier): 3–10% of SNAP-8 Solution; its test cream used 10%, twice daily for 28 days. [1]
- Lubrizol (supplier, later): 3–10% use level; a split-face test used 3% twice daily for 28 days. [3], [15]
- Peptide Initiative: 3–5% once or twice daily for a four-week trial; 10% twice daily ongoing. [9]
- Peptide Mag: 3–10% twice daily, ongoing; separately 100–500 mcg per site weekly by injection for 4–8 weeks. [10]
- Peptide Protocol Wiki: 1–3% for maintenance, 5–10% as an intensive level, morning and evening. [13]
- PeptideDosing: one 10 mg vial in a 200 g batch (0.005%), twice daily for 28 days or more. [37]
- PeptideDosages: concentration arithmetic for a 10 mg vial (0.005% in 200 g; 0.033% in 30 g), labelled as calculations, not a dose. [17]
- Real Peptides: 0.9–1.5 g of pure powder per 30 mL (3–5% as written); separately 500 mcg–2 mg injected every 48–72 hours. [18]
- Peptides.id, JA Performance, VantaPX: 330, 500 and 1,000 mcg once daily by subcutaneous injection over 12 weeks. [7], [8], [44]
- MyPeptideMatch: 50 mcg per facial site 1–2 times weekly for four weeks, then 100 mcg, 12 weeks on and 4–8 weeks off. [24]
- Shandong Sino Pharmatech: 2–5 mg per treatment every 7–10 days for 3–5 sessions. [25]
Is that a genuine consensus?
For topical use, the pages mostly repeat the supplier's sheet, so they agree because they copy one source. For injection, there is no agreement and no data; the daily schedule is syringe arithmetic. A "SNAP-8 Clinical Reference Guide" PDF lists about 20 journal references; none of them matches a real SNAP-8 paper when checked against the Crossref publication database. [43]
What are the registered studies planning?
Nothing. ClinicalTrials.gov has no record for SNAP-8, acetyl octapeptide or octapeptide-3 (checked September 24, 2026). The related records we found test Argireline, not SNAP-8.
SNAP-8, acetyl octapeptide, octapeptide-3
No registered trial of SNAP-8 by any route, in any country registry we searched.
No records. Checked September 24, 2026.
[51]Argireline for blepharospasm (eyelid spasm)
A US government-sponsored study of topical acetyl hexapeptide-8, the shorter parent peptide. It is listed here only because it often appears in SNAP-8 searches.
Terminated. No SNAP-8 results.
[52]What happens when you stop SNAP-8?
We found no study of it. None of the human studies measured skin after participants stopped, and none looked for withdrawal effects or a rebound. That is an absence of data, not proof that nothing happens. [15], [16], [28]
- Changes faded, in the few accounts that say. One person who injected vials said the effect reverted after a few weeks off, in a post whose stated injection volume did not add up. A regular toxin user described using a homemade serum to keep lines softer between treatments, which says little about stopping SNAP-8 itself. [48], [29]
No source describes a taper, and no study has measured how long any effect lasts after stopping.
Does SNAP-8 get through the skin?
Nobody has measured it. No study has tracked intact SNAP-8 crossing human skin, reaching the muscles beneath it or entering the blood. That gap matters, because the proposed mechanism needs SNAP-8 to reach nerve endings in facial muscle, below the skin's outer barrier, its supporting layer and a layer of fat. [1], [53]
Size is part of the problem. SNAP-8 weighs about 1,075 daltons, the unit chemists use for the mass of a molecule. Dermatologists often cite a "500 dalton rule": molecules much above 500 daltons rarely pass intact skin in useful amounts. SNAP-8 is about twice that size and carries several electrical charges, which also slows passage. [54], [55], [50]
The closest evidence comes from its shorter parent. In a laboratory study of a cosmetic cream containing Argireline on donor skin, most of the peptide stayed on the surface, and none was detected in the deeper skin layer or the fluid beneath it under the conditions tested. A 2018 study found the same barrier problem and changed Argireline's chemistry to get more through. SNAP-8 is larger, and no such measurement exists for it. [56], [50]
That is why research has turned to delivery methods. Dissolving microneedle patches load SNAP-8 into tiny needles that dissolve in the skin, and a laboratory method was developed to measure the amount in such patches. A Korean patent attached the SNAP-8 sequence to a "skin-penetrating" peptide; that fused molecule is not SNAP-8. None of these measured SNAP-8 reaching muscle. [28], [53], [57]
What has been tested depends on the route
Topical cream or serum
limited evidence- How people use it
- Supplier level 0.0015–0.005%; most homemade serums far stronger
- Human studies
- Small studies of multi-ingredient products (2011–2023); none of SNAP-8 alone
- What is measured
- No measurement of SNAP-8 crossing skin; its parent Argireline stayed mostly on the surface of donor skin
Microneedle patch or microneedling
limited evidence- How people use it
- Factory-made dissolving patches; homemade serums during needling
- Human studies
- Two patch studies with other actives (2020, 2024); none of homemade serums with needling
- What is measured
- Amount in a patch measured in the lab; delivery to muscle not measured
Subcutaneous or facial injection
no data- How people use it
- Website schedules only (330–1,000 mcg daily; 50–100 mcg per facial site)
- Human studies
- None; no animal study of SNAP-8 alone
- What is measured
- No blood levels or half-life
Swallowed or nasal spray
no data- How people use it
- Occasionally asked about online
- Human studies
- None
- What is measured
- Only a supplier oral safety test in rats
Every human study used a product with other active ingredients.
Creams, serums and patches have small multi-ingredient studies; injection, swallowing and nasal sprays have none.
How long does SNAP-8 last in the body?
Nobody knows. Half-life is the time it takes for the level in the blood to fall by half, and it has never been measured for SNAP-8 by any route, in people or animals. No pharmacokinetic study exists. A half-life, even if measured, would not tell you how long an effect on wrinkles lasts. [1], [51]
Is injected SNAP-8 a stronger version of the cream?
No. Injection is a different exposure, not a stronger dose of the same thing. A cream is meant to act on the face where it is applied; an injection into the abdomen places SNAP-8 far from the facial muscles. No study has tested either subcutaneous injection or injection into the face, and no one has checked whether the body reacts to injected SNAP-8 as a foreign substance. Pages that describe injected SNAP-8 as having "no systemic toxicity" are describing an absence of studies. [1], [7]
Are nasal sprays and capsules the same?
No study in people or animals has tested SNAP-8 swallowed or sprayed into the nose, and we found no published amount for either route. In public forums, questions about a nasal spray were answered with "topical only". The only oral test was the supplier's acute safety test in rats, which measured survival, not an effect. [58], [1]
How should SNAP-8 be stored, and how long does it last?
We found no published stability study of SNAP-8 in a homemade serum. Storage information comes from the supplier and a research-chemical company. [1], [2], [54]
- The supplier's solution. The 2005 technical sheet says to keep the solution and powder in a cool, dark, clean place for a shelf life of at least 12 months, or at 4 °C for at least 18 months. It notes that refrigeration can make the preservative settle out without harming the product. The 2015 solution has a stated shelf life of 24 months if stored clean, cool and dark. [1], [2]
- Pure powder. A research-chemical supplier states that its solid SNAP-8 is stable for at least four years at −20 °C, and it does not recommend keeping a water-based solution for more than one day. [54]
- Adding it to a product. The supplier adds SNAP-8 at the end of manufacturing, below 40 °C. Its solution is specified at a mildly acidic pH of 3.0–5.0; that is a product specification, not proof that other pH levels break it down. [1], [2]
- Homemade serums. Community practice is to refrigerate once mixed, with shelf-life beliefs from a few weeks to 90 days and no data behind any of them. Generic peptide pages give 28 days for vials mixed with bacteriostatic water, a rule borrowed from injectable vials, not a SNAP-8 test. Homemade water-based serums without a preservative can grow microbes. [7]
Color, clarity and "lab testing" claims on a vial say nothing about identity or strength; no independent test of research-vial SNAP-8 has been published. This guide does not cover mixing technique; the Academy note below covers practical handling basics.
What do we actually know about SNAP-8 in people?
Every published human study of SNAP-8 tested a finished product that also contained other active ingredients: creams, serums, a device treatment and microneedle patches. Eight published reports are confirmed to include SNAP-8, plus one 2026 study we could not confirm. Only one had a comparison group, and most were run or funded by the company behind the product. [27], [59], [34], [60], [33], [15], [16], [28], [61]
Looking better after a new product is real to the person seeing it. Working out why is a separate task: skin changes with seasons, sun, sleep, weight and other products, and people using a new cream tend to expect results. Controlled studies help separate those effects from the product itself.
Where do the "63%" and "30% better than Argireline" figures come from?
Both come from one unpublished supplier test. Lipotec measured wrinkle depth around the eyes from silicone skin impressions in 17 healthy women who used a cream containing 10% of its SNAP-8 solution (about 0.005% SNAP-8) twice daily for 28 days. The average reduction was 34.98%; the best single result was 63.13%. The "up to 63%" repeated online is that one best result. [1]
"About 30% more active than Argireline" compares this test with a separate 2001 test of an Argireline cream in 10 different women, which averaged 27.05%. The supplier's chart also shows a placebo result of 2.99%, without describing how the placebo group was set up. A comparison across two tests, years apart, in different people, is not a head-to-head trial. [1]
Lubrizol's later figure, "up to 38%" in a month, came from a split-face test of a cream with 3% of the solution. The average reduction in that test was 7.1%. [3], [15]
Where the famous numbers come from
Reduction in wrinkle depth from the start of each test. Unpublished manufacturer tests, not peer reviewed.
Supplier test, 2005
17 women · cream with 10% of the SNAP-8 solution · twice daily · 28 days
- Best single result
- 63.13%
- Average
- 34.98%
- Placebo (design not described)
- 2.99%
Separate Argireline test, 2001
10 different women · Argireline cream
- Average
- 27.05%
Later supplier test
Cream with 3% of the solution · split face · about a month
- Best result (“up to 38%”)
- 38%
- Average
- 7.1%
Unpublished manufacturer tests, not peer reviewed. '30% more active than Argireline' compares averages from two different tests (34.98 vs 27.05).
'Up to 63%' is one person's best result; averages were about 35% in one small test and 7% in another.
What did the published studies find?
| Study | What researchers reported | What it cannot establish |
|---|---|---|
| Facial serum, 2011 | 34 women used a serum listing SNAP-8 among several actives for 12 weeks, with no comparison group. Investigators graded fine lines 27% and coarse wrinkles 15% better. | Any effect of SNAP-8: the strength was not stated and several actives were present. The product's company funded the study, and the lead author worked for it. [27] |
| Three serums, 2013 | 30 people in three groups of 10 for 12 weeks; only the women's serum contained SNAP-8, with retinol and other actives. Its wrinkle score fell from 1.8 to 1.1. One person in that group had an acne-like breakout and one had burning. | A SNAP-8 effect: no comparison product and many other ingredients. [59] |
| Device treatment, 2013 | One man had a device push a five-peptide serum containing SNAP-8 into the skin in 10 of 12 sessions; doctors rated dark circles 75–90% better. | Anything about wrinkles, or about SNAP-8 alone. [34] |
| Peptide serum, 2016 | 29 women used a serum with seven peptides, including SNAP-8, Argireline and another muscle-signal peptide, for 12 weeks, added after 2 weeks on a supporting skin-care regimen. Line and wrinkle grades improved from the start. Participants reported more redness and flaking at week 2, before the serum was added, and redness lasted to week 10; the investigator found no increase, and the summary says there were no adverse events. | A SNAP-8 effect; two of the three authors worked for the company behind the serum. [60] |
| Microneedle patch, 2020 | A patch containing SNAP-8 and four other actives was used for 12 weeks; fine lines fell 25.8% and skin hydration rose 15.4%. | Which ingredient, or the patch itself, caused the change. We reviewed the abstract only. [33] |
| Peptide serum, 2023 | 31 of 33 women completed 12 weeks of twice-daily use of a multi-peptide serum; crow's-feet lines were graded 32% better, with no comparison group. | A SNAP-8 effect; the study was company-funded. [15] |
| Face and neck serum, 2023 | 47 of 50 women completed 24 weeks of twice-daily use of a serum with about five peptides; lines graded 40% better, wrinkles 23%. | A SNAP-8 effect; company-funded, no comparison group. [16] |
| Microneedle patch, 2024 | 21 of 24 adults wore a patch with 0.03% SNAP-8 plus two other actives under one eye and a plain hyaluronic-acid patch under the other: nightly for 14 days, then every third day to day 28. Several roughness measures improved more on the active side; elasticity did not differ. | A SNAP-8 effect: the active patch had two other actives the comparison lacked. The patch maker funded the study. [28] |
| Serum and cream regimen, 2026 | 47 women used a serum and cream twice daily for 90 days, with large reductions in measured roughness. | Whether SNAP-8 was present: the abstract does not list it, and we could not open the full text to confirm. [61] |
What the SNAP-8 human studies tested
Icons, left to right: other active ingredients, SNAP-8 strength stated, comparison group (tick = yes, cross = no).
- Facial serum, 2011
- Serum · People: 34 · Other actives: yes · Strength stated: no · Comparison group: no · Company ties: yes
- Three serums, 2013
- Serum (1 of 3 arms) · People: 10 in SNAP-8 arm · Other actives: yes · Strength stated: no · Comparison group: no · Company ties: not stated
- Device treatment, 2013
- Serum pushed in by device · People: 1 · Other actives: yes · Strength stated: no · Comparison group: no · Company ties: none declared
- Peptide serum, 2016
- Serum · People: 29 · Other actives: yes · Strength stated: no · Comparison group: no · Company ties: yes
- Microneedle patch, 2020
- Patch · People: Not in abstract · Other actives: yes · Strength stated: no · Comparison group: no · Company ties: yes
- Peptide serum, 2023
- Serum · People: 31 · Other actives: yes · Strength stated: no · Comparison group: no · Company ties: yes
- Face and neck serum, 2023
- Serum · People: 47 · Other actives: yes · Strength stated: no · Comparison group: no · Company ties: yes
- Microneedle patch, 2024
- Patch · People: 21 · Other actives: yes · Strength stated: yes (0.03%) · Comparison group: yes (plain patch; 2 other actives differ) · Company ties: yes
Company ties = funded by or authored with the product's maker. A 2026 regimen study is omitted because its SNAP-8 content could not be confirmed.
All eight products had other active ingredients; one study had a comparison group; none tested SNAP-8 alone.
Where studies report percentages, they are changes from the start of the study, graded by investigators or measured by skin imaging. Without a comparison group, those changes include everything else that happened during the study, including the moisturizer and sunscreen many participants were given. [15], [16]
What would a useful improvement look like?
Wrinkle studies measure different things: skin impressions read by a profilometer, photographs graded by an investigator, skin-surface imaging, hydration, or how people rate themselves. These can disagree. A serum can make skin feel smoother within minutes simply by hydrating it, which is different from a line becoming shallower. [1], [16]
For a person, a useful improvement is one that shows in consistent photographs taken in the same light, lasts beyond the first weeks and does not come with irritation. The more helpful accounts say what else changed at the same time, such as a toxin appointment, a new retinoid or microneedling. [42]
Has anyone tested SNAP-8 on its own, or by injection?
No. We found no study, published or registered, that tests SNAP-8 as the only active ingredient against a matched product without it, and no human or animal study of injected, swallowed or nasal SNAP-8. The closest thing to an injection study is a 2025 rat experiment in which wounds were injected with a plant-extract mixture listing SNAP-8 among about 20 ingredients, at an unstated amount. [51], [36]
How might SNAP-8 work?
The proposed mechanism comes from the supplier's own laboratory work. The idea is that SNAP-8 mimics the start of the SNAP-25 protein and slightly disrupts the machinery nerve endings use to release acetylcholine, the chemical signal that tells a muscle to contract. Less signal would mean less muscle pull and softer expression lines. [1]
The SNARE complex
Nerve cells keep their chemical messengers in tiny bubbles called vesicles. To release them, three proteins, including SNAP-25, twist together into the SNARE complex, which pulls a vesicle against the cell's edge so it can empty. The supplier proposes that SNAP-8, as a copy of the first part of SNAP-25, competes for a place in this complex and makes it slightly less stable. [1], [62]
What the laboratory tests showed
In the supplier's unpublished test with adrenal-gland cells (a common stand-in for nerve cells), SNAP-8 halved the release of chemical messengers at a concentration of about 55 micromoles per litre, compared with 110 for Argireline and about 0.026 for botulinum toxin type A. In that test, the toxin worked at a concentration roughly 2,000 times lower. These are concentrations in a dish, not doses for a person, and no independent laboratory has published a repeat. [1]
How is that different from botulinum toxin?
Botulinum toxin is an enzyme that cuts one of the SNARE proteins, so the nerve ending cannot release acetylcholine until it gradually recovers and forms new nerve endings. It is injected into the muscle by a clinician. SNAP-8 is proposed to compete gently and reversibly, and it is applied to the skin surface, far from the muscle. The two are not interchangeable, and "Botox in a bottle" is a marketing idea, not a finding. [63], [1]
What has not been shown
No study has shown that SNAP-8 applied to intact skin reaches facial muscles, reduces acetylcholine release in people, or weakens a muscle. The chemistry and cell findings explain why researchers were interested; they do not show the effect happens in a face. [56], [55]
What are the risks and unanswered questions?
Is SNAP-8 safe?
On the skin at the supplier's strengths, the limited evidence is reassuring; at the much higher homemade strengths, or by injection, its safety has not been studied. The supplier reports that a 0.05% SNAP-8 solution caused no allergic sensitization when repeatedly patched onto the skin of 50 volunteers, and its laboratory screens found no cell damage or gene damage. It also reports no acute toxicity in rats given a single oral dose of 2,500 mg per kg, the amount tested. None of these tests has been published in a journal. [1], [2]
Small, short studies can miss uncommon reactions and problems that take months to appear. The product studies ran for 4 to 24 weeks and measured skin appearance and irritation, not blood tests. We found no published safety assessment of SNAP-8 itself; a 2026 industry framework for judging cosmetic peptides lists it among nerve-signal peptides without any SNAP-8 data. [15], [16], [64]
What side effects have been reported?
- In the product studies. One acne-like breakout and one case of burning among 10 people using a SNAP-8 serum that also contained retinol; in another study, participants reported more redness and flaking during a two-week run-in on a supporting skin-care regimen, before the SNAP-8 serum was added, with redness lasting until week 10; mild discomfort or irritation in 2 of 31 people, judged unrelated. Because every product had several actives, none of these can be pinned on SNAP-8. [59], [60], [15]
- In public forums. Redness with a commercial SNAP-8 and GHK-Cu serum, dryness, a mild numbing feeling, tingling, and one person's month of contact dermatitis after a homemade mix. [65], [66], [67], [68]
- In community education groups. A forehead breakout after rubbing a mixed vial straight onto the skin, dryness blamed on bacteriostatic water, redness and itching from homemade kits, and, at extreme strengths, a stiff "frozen" face. The component responsible was never clear.
Can SNAP-8 make the face or eyelids droop?
It has not been shown, and no case report of drooping from SNAP-8 exists in the medical literature. A few accounts raise the question. On a seller's own review page, one customer who put a SNAP-8 serum on their eyelids said they felt "a strong resistance closing my eyes" for nearly an hour. Another person described brow-raising becoming harder for a while after applying a commercial product. In community education groups, one member reported one-sided sagging near the mouth with new deep lines after applying a strong homemade SNAP-8 and Syn-Ake serum to the smile lines, which improved after stopping there. [69], [67]
These single reports cannot show cause, but they point to sensible limits: keep products away from the eyelids and eyes, and stop using a product on any area that starts to droop or move unevenly.
Could microneedling with a homemade serum cause problems?
Yes. Microneedling pushes whatever is on the skin into it. Doctors have reported granulomas, firm inflamed lumps that can last months, after microneedling with topical serums that were not made to go into the skin; a 2025 review found 15 such cases, most involving a vitamin C serum. None involved SNAP-8, but homemade serums are not sterile or tested for this use. [20], [21]
Could product quality change the risk?
Yes. The supplier's solution is made to a cosmetic specification, but research-chemical vials and bulk powders come with no independent test of what they contain. A cosmetic formulator in a public forum suggested that some vials sold as SNAP-8 may contain Argireline instead; that is an opinion, but no published test has checked. A "research use only" label says nothing about identity, purity or sterility, and reconstituting a powder does not make it safe to inject. [41], [54]
Is SNAP-8 legal? Is it FDA-approved?
Checked September 24, 2026. Rules differ by country and change quickly.
United States. SNAP-8 is sold as a cosmetic ingredient. The FDA does not approve cosmetics before sale, and it says that products intended to change the structure or function of the skin are drugs. SNAP-8 is not an approved drug and is not on the FDA's lists of substances nominated for pharmacy compounding. [6], [70]
European Union. The EU cosmetic ingredient database lists ACETYL OCTAPEPTIDE-3 as a moisture-holding and skin-conditioning ingredient, with no restrictions. A database listing is information, not an approval. [4]
Canada. Health Canada's list of prohibited and restricted cosmetic ingredients does not include SNAP-8. Its April 2026 warning about unauthorized injectable peptides names other peptides, such as GHK-Cu and BPC-157, but not SNAP-8. [71], [72]
Australia. The TGA's 2026 warnings about unapproved peptide products do not name SNAP-8. [73]
A "research use only" label does not make a product legal to sell for injection into people.
Is SNAP-8 banned in sport?
It is not named on the World Anti-Doping Agency's 2026 or 2027 lists. Category S0 bans any substance with no current government approval for human therapeutic use. Whether that covers an injected research vial of a cosmetic peptide is a reasonable question; no anti-doping body has ruled on it, and topical cosmetics are not addressed. Athletes should ask their anti-doping organization before injecting it. [74], [75]
Who should be especially cautious?
These groups have no safety data. That is a reason for caution, not proof of harm.
- Pregnancy and breastfeeding. No SNAP-8 study included pregnant or breastfeeding people.
- Conditions that weaken muscles, such as myasthenia gravis or other nerve-muscle disorders. No SNAP-8 study included people with these conditions. Labels for botulinum toxin, which acts on the same nerve-to-muscle signal far more strongly, warn that these conditions can magnify its effects. Ask a clinician before using a product designed to relax facial muscles. [63]
- Sensitive or eczema-prone skin, or known reactions to skin products. Local reactions were the main problems in the studies. Patch-test first.
- Anyone planning microneedling with a homemade serum. See above. [20]
- Under 18. No studies include young people. This guide is written for adults.
- Competitive athletes considering injection. See the sport question above. [75]
Has SNAP-8 been tested alongside other treatments?
Not in any controlled way. Every study combined SNAP-8 with other actives, such as retinol, Argireline, vitamin C forms or hyaluronic acid, so combinations are the only way it has been tested, but none compared the combination with and without SNAP-8. Stacking several skin actives can add up to irritation. [59], [60], [28]
No study has looked at SNAP-8 with botulinum toxin. Claims that you should wait a set time after a toxin appointment, or that SNAP-8 stretches the time between appointments, have no data behind them either way. Tell the clinician who gives your injections what you apply at home, and bring your full list of products and medicines to a pharmacist or doctor.
What should be monitored while using SNAP-8?
There is no official monitoring plan, because SNAP-8 is a cosmetic ingredient with no medical label. What follows is what the studies measured. It can help you prepare questions for a clinician; it is not a personal testing plan. [6], [4]
What did the human studies check?
- Skin appearance. Investigator grading of lines and wrinkles, skin impressions, surface imaging, hydration and elasticity. [1], [15], [16], [28]
- Local tolerability. Redness, flaking, dryness, stinging and burning, rated by investigators or participants. [60], [16]
- Allergy testing. The supplier's repeated patch test in 50 volunteers. [1]
- Nothing in the blood. No study measured blood tests, vital signs or muscle strength, and none looked for SNAP-8 in the body. [16], [51]
Which signals matter, and why?
| Why it matters | What sources measured or flagged | Tracking category |
|---|---|---|
| Irritation and allergy | Redness, flaking and burning in product studies; dermatitis after a homemade mix in a forum account | Skin Health; Side Effect Burden |
| Muscle movement and symmetry | Not measured in any study; single accounts of eyelid resistance and one-sided sagging | Side Effect Burden |
| The change you care about | Lines at rest and in motion; consistent photos in the same light, at the same times of day | Skin Health |
| Other treatments at the same time | Toxin appointments, retinoids, microneedling and other peptides change the picture | Side Effect Burden; Skin Health |
These are reasons to watch, not findings from SNAP-8 users. Discuss with a clinician whether anything else makes sense for you. [60], [20]
What do people in public communities report?
Public discussions and community education groups describe softer forehead lines, nothing at all after a year, and a lot of confusion about strength. Almost every account involves a homemade serum that also contains other actives, and almost none includes measurements. [76], [77]
What do the positive reports look like?
Most positive reports are about forehead and frown lines looking softer after a few weeks to a few months, usually with GHK-Cu or other peptides in the same serum. One person said forehead lines became "less deep and thinner" after two months of a four-peptide mix. Another, who had never used toxin, said a marketed 9% serum visibly reduced expression lines over three months, though the label did not say what the 9% referred to. [76], [78]
The more detailed accounts include changes over time. One person made a serum with one 10 mg vial in 30 mL of hyaluronic acid, used it twice daily and reported softened fine lines by two months; doubling the amount made the face feel uncomfortably "set". Another said a morning frown line stopped appearing after using two vials in about 60 mL of mixed serums, while also taking injectable peptides. [38], [79]
In community education groups, positive reports are mostly general praise for how the skin looks, and self-judged. Specific claims include softer lines, more even tone and a "tight" feeling soon after applying, which is more likely the serum drying on the skin than a muscle effect. Only a few members posted photographs.
Does everyone describe an improvement?
No, and the nonresponse reports are specific. "Snap 8 did nothing for a whole year", one person wrote; another saw no "botox" like effect after a couple of months of daily use while crediting GHK-Cu for better skin quality. Others saw no benefit at double the usual strength in their serum, nothing after two months twice daily following dermarolling, and nothing when trying it twice with GHK-Cu. [77], [42], [76], [80]
In community education groups, "no change" reports were more common among people using SNAP-8 on its own than among those mixing it with GHK-Cu. That fits the idea that the copper peptide or the serum base may explain some of the positive reports, though selected accounts cannot prove it.
How long did people say it took?
Answers ranged from "literally a few days" to five months, and one person saw no difference at six weeks. Fast changes are usually about skin feel; changes in lines were more often described after one to three months. Educators in community education groups suggest judging at 2 to 4 months. These are impressions, not measured averages. [81], [67], [82]
What about unwanted effects?
Most are local and mild: redness, dryness, tightness, tingling or numbness, and occasional breakouts. The harder cases involve very strong homemade mixes, a stiff "frozen" face or one-sided sagging near the mouth, and eyelid use, after which one reviewer felt resistance closing the eyes for about an hour. One person developed contact dermatitis lasting a month after mixing their own serum. [65], [68], [69]
Does a "tight" or "frozen" feeling mean it is working?
Not necessarily. A tight feeling within minutes of applying a serum is usually the product drying on the skin, which hyaluronic-acid bases do by themselves. A stiff face at very high strengths is a reason to stop and dilute, not a sign of success. [31], [38]
How can you judge a SNAP-8 story?
Useful questions to ask: What exactly was used, and at what strength of pure SNAP-8? Was it SNAP-8 alone, or mixed with GHK-Cu or other peptides? Was it a cream, microneedling or an injection? What else changed: toxin appointments, retinoids, weight, season? Were photos taken in the same light? What happened weeks later?
These selected discussions help identify experiences that research should examine. They are not a survey of all users, a response rate or a substitute for controlled studies.
How does SNAP-8 compare with Argireline, GHK-Cu and botulinum toxin?
These are the ingredients and treatments SNAP-8 is most often compared with or mixed with. The table compares what each is and how much human evidence exists; the route column describes typical use, not tested doses.
| Ingredient or treatment | What it is | Typical route | Human evidence | Approval status |
|---|---|---|---|---|
| SNAP-8 (this guide) | Eight-amino-acid peptide based on SNAP-25 [1] | Creams and serums; injection only on some websites [1], [7] | Multi-ingredient product studies; none of SNAP-8 alone [15], [28] | Cosmetic ingredient; not an approved medicine [4] |
| Argireline (acetyl hexapeptide-8) | SNAP-8's six-amino-acid parent [1], [35] | Creams and serums | A 60-person placebo-controlled trial of Argireline itself, plus others [83] | Cosmetic ingredient |
| GHK-Cu | A three-amino-acid copper peptide found in human blood; often mixed with SNAP-8 | Serums; injection on protocol websites | Small skin and wound studies; none of subcutaneous injection | Not an approved medicine |
| Botulinum toxin type A | A prescription nerve-blocking protein [63] | Injected into specific muscles by a clinician | Large controlled trials behind approved products [63] | Approved prescription medicine for frown lines [63] |
The real differences are in evidence and route. Argireline, SNAP-8's shorter parent, has a placebo-controlled trial of its own, and its poor skin penetration is measured; SNAP-8 has neither. Botulinum toxin is an approved medicine with large trials, delivered straight into the muscle. No study has compared SNAP-8 with any of these, so the table cannot say which works better. [83], [56], [63]
Common questions about SNAP-8
Is SNAP-8 the same as Argireline?
No. SNAP-8 (acetyl octapeptide-3) is Argireline's six amino acids plus two more, so it is a related but different molecule. Argireline has its own studies, including a placebo-controlled trial, and those results cannot simply be assigned to SNAP-8. Some pages confuse the two, calling SNAP-8 "acetyl hexapeptide-8", which is Argireline's name. [1], [83], [68] See what SNAP-8 is.
Does SNAP-8 work like Botox?
Not in any demonstrated way. Its maker designed it to interfere gently with the same nerve-to-muscle signal that botulinum toxin blocks, but that was shown only in laboratory tests, where the toxin worked at roughly 2,000 times lower concentrations. The toxin is injected into the muscle; SNAP-8 is applied to the skin, and nobody has shown it reaches the muscle. Toxin users in public forums describe it at most as a way to keep lines softer between appointments. [1], [29], [30] See how it might work.
Does Daxxify contain SNAP-8?
No. This claim circulates in community discussions, but the FDA-approved label for Daxxify (daxibotulinumtoxinA) lists its stabilizing peptide as RTP004, a 35-amino-acid peptide, alongside histidine, polysorbate 20 and trehalose. RTP004 is a different molecule from SNAP-8, which has eight amino acids, and it is an excipient inside an injected medicine, not a wrinkle treatment. [63] See the comparison table.
Can you inject SNAP-8?
No study has tested it, so there is no known safe or effective injected amount. The injection schedules online are syringe arithmetic for a 10 mg vial, and research vials are not made or tested as sterile injectables. Injection also places SNAP-8 far from the facial muscles it is meant to affect. Most public forum discussions advise against it. [7], [8], [46] See the injection schedules and where they come from.
How long does SNAP-8 take to work?
There is no reliable answer. The supplier measured its cream at 28 days, and the product studies measured at 4 to 24 weeks. Community accounts range from a few days, usually about skin feel, to several months for lines, alongside many reports of no change. [1], [16], [77] See what people reported.
What does "10% SNAP-8" on a label mean?
Usually 10% of the supplier's ready-made solution, which is itself only about 0.05% SNAP-8, so the product contains about 0.005% SNAP-8. Some labels do not say which they mean. A product with 10% pure SNAP-8 would be about 2,000 times stronger than the supplier's level and has never been studied. [1], [2], [23] See how strong homemade serums are.
Can you mix SNAP-8 with GHK-Cu?
Most people do, and several human studies used SNAP-8 alongside other peptides. The claim that copper "inactivates" SNAP-8 has no test behind it either way, and no study has tested the two together. Mixing actives makes it harder to tell which one helped or caused a reaction. [40], [60] Read the GHK-Cu guide for the copper peptide itself.
Is it legal to buy SNAP-8?
Skin-care products and cosmetic-grade SNAP-8 solution are sold openly as cosmetic ingredients, and the EU lists it without restrictions. It is not an approved medicine anywhere we checked, and a "research use only" label on a vial does not make it legal or safe to inject. [4], [6] See the dated legal-status summary.
Glossary
Plain explanations of the route, dosing and research terms used in this guide. Underlined terms in the text link here.
- Acetylcholine
- The chemical signal nerve endings release to make a muscle contract.
- Adverse event
- A harmful or unwanted medical event reported after someone used a treatment. A report alone does not prove the treatment caused it.
- Amino acid
- A small chemical building block. Chains of amino acids make up peptides and proteins.
- Animal study
- Research in animals such as rats or mice. It shows what a substance does in a living body, but results in people can differ.
- Argireline
- The trade name for acetyl hexapeptide-8, a six-amino-acid cosmetic peptide. SNAP-8 is Argireline plus two more amino acids.
- Bacteriostatic water
- Sterile water with a small amount of benzyl alcohol added to slow bacterial growth. It is made for mixing injectable powders; some people find it drying on the face.
- Botulinum toxin
- A prescription protein injected into muscles to relax them, used for frown lines and some medical conditions. It works by cutting a protein nerve endings need to release acetylcholine.
- Cell study (in vitro)
- Research on cells grown in a dish. It gives early clues about biology, but it is far from proof of benefit in people.
- Compounding
- When a pharmacy prepares a customized medicine from individual ingredients. In the US, federal lists control which bulk ingredients pharmacies may use.
- Contact dermatitis
- An itchy, red skin rash caused by something that touched the skin, either by irritation or by an allergic reaction.
- Controlled trial
- A study that compares people who receive a treatment with a similar group who do not, often receiving a placebo instead. Randomly assigning people to each group makes the comparison fairer.
- Cosmetic ingredient
- An ingredient used in products meant to cleanse or beautify, such as creams and serums. Cosmetics do not go through drug approval, and they may not claim to treat disease.
- Course and cycle
- A course is the period of repeated use, such as 28 days. A cycle is a course plus a planned break before any further use.
- Excipient
- An inactive ingredient in a medicine, such as a stabilizer or preservative, as opposed to the active ingredient.
- Expression lines
- Wrinkles that form where facial muscles repeatedly pull on the skin, such as forehead lines, frown lines between the brows and crow's feet.
- Granuloma
- A firm lump of inflamed tissue the body forms around something it cannot clear, such as a foreign substance pushed into the skin.
- Half-life
- The time it takes for the measured level of a substance in the blood to fall by half. It is not the same as how long an effect lasts.
- Hyaluronic acid
- A moisture-holding substance found naturally in skin and widely used in serums. It makes skin feel smoother and plumper by itself.
- Intradermal
- Injected into the skin itself rather than under it, as in some cosmetic procedures.
- mcg and mg
- Micrograms and milligrams. 1 mg equals 1,000 mcg. Injection pages give SNAP-8 amounts in mcg; vials and jars are sold in mg.
- Microneedling
- A skin treatment that makes many tiny channels with fine needles, by device, roller or dissolving patch. Anything on the skin can be pushed into those channels.
- Peptide
- A short chain of amino acids. SNAP-8 is a chain of eight.
- Percent strength
- How much of an ingredient is in a product by weight or volume. For SNAP-8, check whether it means the share of the supplier's 0.05% solution or of pure SNAP-8; the two differ about 2,000-fold.
- Pharmacokinetics
- How the body absorbs, moves, breaks down and removes a substance. It has not been studied for SNAP-8.
- Placebo
- A dummy treatment with no active ingredient, such as a plain cream or patch, used as a comparison in studies.
- Preclinical research
- Studies done before research in people: cell studies and animal studies.
- Reconstitution
- Mixing a freeze-dried powder with a liquid. The amount of liquid sets how much peptide each unit or drop holds.
- Research use only
- A label on products sold for laboratory research. It does not mean a product is approved, tested for human use or legal to sell as a medicine.
- SNARE complex
- A group of three proteins, including SNAP-25, that twist together to let a nerve ending release its chemical messenger. SNAP-8 is designed to resemble part of SNAP-25.
- Subcutaneous (SC)
- Injected into the fatty layer just under the skin. This is the route injection pages describe for SNAP-8 vials, though no study has tested it.
- Syringe units
- Markings on an insulin syringe that measure volume. On a U-100 syringe, 100 units equal 1 mL. The amount of peptide per unit depends on how much liquid was added to the vial.
- Titration
- Adjusting a dose or strength in steps, usually starting lower and increasing if needed.
- Topical
- Applied to the skin, as a cream, gel or serum.
- WADA
- The World Anti-Doping Agency, which publishes the list of substances banned in sport.
- Withdrawal and rebound
- Withdrawal effects are symptoms caused by stopping a substance. A rebound is a problem returning worse than before after stopping. Neither has been studied for SNAP-8.
Supporting research: laboratory and animal studies
Explore the laboratory, animal and Argireline studies
These studies explain why SNAP-8 was developed and why its delivery is questioned. None tested SNAP-8 alone in people, and none of their amounts can be turned into a human dose.
The supplier's laboratory tests
Lipotec's 2005 dossier describes a test-tube experiment in which SNAP-25 fragments interfered with the assembly of the SNARE complex, and a test in adrenal-gland cells in which SNAP-8 reduced the release of adrenaline and noradrenaline, with half the release blocked at about 55 micromoles per litre [1]. The dossier notes that these cells release catecholamines, not acetylcholine, and are used as a model because nerve cells are harder to grow. The same document reports no cell damage in skin cells, a negative test for gene damage and an eye-irritation screen suggesting it is "potentially not irritating" [1]. None of this was published in a journal.
Animal studies
The supplier reports a single-dose oral test in rats that found no acute toxicity at 2,500 mg per kg, the amount tested [1]. In a 2025 study of 18 rats, wounds in the treated group were injected with a plant-extract mixture listing SNAP-8 among about 20 ingredients, including Argireline and GHK-Cu; treated wounds grew a thicker outer skin layer by day 14, an effect of the mixture, not of SNAP-8 [36].
Measuring and delivering SNAP-8
A 2020 laboratory method measures very small amounts of SNAP-8 by mass spectrometry and was applied to a microneedle patch loaded with it [53]. A Korean patent fused the SNAP-8 sequence to a skin-penetrating peptide; the fused molecule is not SNAP-8 [57]. A 2018 review of SNARE-based peptides describes SNAP-8 as the longer version of Argireline developed for wrinkles, without new SNAP-8 experiments [62].
Argireline, the parent peptide
Argireline, SNAP-8's six-amino-acid parent, reduced SNARE assembly and messenger release in the laboratory [35]. A randomized, placebo-controlled trial of Argireline cream in 60 people reported more improvement in wrinkles around the eyes than placebo [83]. In a skin-penetration study, very little Argireline passed into donor skin [56], and a 2018 study modified Argireline's chemistry to improve penetration [50]. These findings are about a different molecule and cannot be counted as SNAP-8 evidence.
How this guide was researched
This guide is built from a thorough review of the sources cited throughout it: published scientific studies, manufacturer technical documents, registry searches, regulatory documents and published protocol descriptions. We also reviewed public online forums and community education groups where people describe their own experiences with SNAP-8.
The guide cites 83 sources, including 16 original scientific papers (11 human studies and 5 laboratory and animal studies). Outside the manufacturer's own tests, very little original research on SNAP-8 exists. Each type of source answers a different question. Studies show what researchers measured. Protocol descriptions show how SNAP-8 is typically used. Personal accounts show what individual people experienced. Every numbered citation links to its entry below, labeled by source type.
How this guide was made
Research and drafting were AI-assisted. Every cited source was checked against the original, and the guide was reviewed and edited by Doserly before publication. It has not had an independent clinical review, and Doserly does not currently have medical reviewers. Doserly makes a medication and health-tracking app and runs Doserly Academy, both of which are promoted in this guide. Read our editorial policy for how guides are researched, updated and corrected.
This guide is for educational purposes. It summarizes what the reviewed sources report so the research is easier to understand; it is not medical advice. For a deeper dive, or to check any point for yourself, go straight to the cited sources.
Explore the sources
These are the documents cited in this guide. Studies, manufacturer documents, website advice and personal accounts answer different questions. A source being listed does not mean every statement on its page is endorsed.
Showing 83 sources
- 01
SNAP-8: An Anti-Aging Peptide (technical dossier PD017, rev. 3) ↗
Manufacturer dossier (unpublished tests)
Full document reviewed.
Result detail: 17 women, cream with 10% SNAP-8 Solution twice daily for 28 days: average wrinkle-depth change −34.98%, best single result −63.13%; Argireline comparison from a separate 2001 test in 10 women. Not peer reviewed.
- 02
Product Information Dossier: SNAP-8 peptide solution C (P06-PD017) ↗
Manufacturer specification
Full document reviewed: 0.045–0.055% acetyl octapeptide-3, pH 3.0–5.0, shelf life 24 months. Prints CAS 1253115-75-1, which differs from registry records.
- 03
SNAP-8 peptide solution C (product page, archived 24 Jan 2022) ↗
Manufacturer product page
Archived page reviewed: use level 3–10%; "wrinkle depth is reduced up to 38% in one month".
- 04
CosIng ingredient record: ACETYL OCTAPEPTIDE-3 (substance 82188) ↗
Regulatory database
Record reviewed through the official search service: functions humectant and skin conditioning; no annex restriction; status active.
- 05
ACETYL OCTAPEPTIDE-3: substance record UNII 8K14HJF88S ↗
Substance registry
Record reviewed through the registry's data service: sequence EEMQRRAD; synonyms include SNAP-8, acetyl glutamyl heptapeptide-3 and acetyl octapeptide 1.
- 06
- 07
SNAP-8 Research, Dosing & Protocols ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
Limitation: its research links include an Argireline study and an unrelated primary-care study presented as SNAP-8 research.
- 08
SNAP-8 (10 mg Vial): Dosing, Reconstitution & Cycle Guide ↗
Dosing website
Page did not open for us; its dosing text was read from the search-engine copy. Protocol-source claim, not a tested dose.
- 09
Snap-8 dosing & administration ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 10
SNAP-8: Dosing & Research Guide ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 11
SNAP-8 peptide solution C ↗
Ingredient retailer
Product page reviewed; restates the supplier's 3–10% use level.
- 12
SNAP 8 Peptide Ingredient for Fine Lines and Wrinkles ↗
Ingredient retailer
Product page reviewed: "This refers to the solution as supplied, not the pure peptide."
- 13
SNAP-8 Dosing and Application Protocols ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 14
Snap-8: Mechanism, Dosing & Research ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 15
Peptide-pro complex serum: Investigating effects on aged skin ↗
Human study (uncontrolled)
Full text reviewed. Its reference 17 describes the supplier's 3% split-face test (up to 38%, average 7.1%).
- 16
The Benefits of a Multimechanistic Antiaging Skin Technology ↗
Human study (uncontrolled)
Full text reviewed.
- 17
SNAP-8 Dosage: 10 mg Topical Research Guide ↗
Dosing website
Current page reviewed; archived copies from March and May 2026 carried a 330/500/1,000 mcg daily injection schedule that the current page no longer gives.
- 18
Snap-8 Dosage Protocol Guide ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
Limitation: treats a 3–5% use level as pure powder (0.9–1.5 g per 30 mL).
- 19
How to Use Snap-8 Peptide: A Professional Lab Guide ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
Limitation: describes 3 g of powder in 27 g of base for a 10% product.
- 20
Facial allergic granulomatous reaction and systemic hypersensitivity associated with microneedle therapy for skin rejuvenation ↗
Case series (not SNAP-8)
Original abstract reviewed: three women with facial granulomas after microneedling with topical products; two had used the same vitamin C serum.
- 21
Granulomatous Reactions From Microneedling: A Systematic Review of the Literature ↗
Systematic review (not SNAP-8)
Original abstract reviewed: 13 studies describing 15 patients; motorized pens and topical vitamin C implicated in most cases.
- 22
SNAP-8 Peptide Serum Formulation Guide ↗
Formulation guide
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 23
SNAP-8 Peptide Serum 10% ↗
Product page
Product page reviewed; the label does not state whether 10% refers to the supplier's solution or pure peptide.
- 24
SNAP-8 Dosing Protocol: 10 mg Vial, Anti-Wrinkle Facial Injection Guide ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 25
SNAP-8 (powder for injection) ↗
Seller page
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 26
Snap-8 Peptide Canada: Topical Botox Alternative ↗
Seller guide
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 27
Efficacy and tolerability of a facial serum for fine lines, wrinkles, and photodamaged skin ↗
Human study (uncontrolled)
Full text reviewed.
Limitation: 34 women, no comparison group; SNAP-8 one of several actives at an unstated strength.
- 28
Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities ↗
Human study (split-face comparison)
Full text reviewed.
Result detail: 0.03% SNAP-8 with 5% ascorbic acid 2-glucoside and 4% cyclic lysophosphatidic acid versus a hyaluronic-acid patch; 21 of 24 completed; funded by the patch maker.
- 29
Botox Not Lasting ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 30
Snap 8 ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 31
Acetyl octapeptide-3 is a miracle ingredient for dehydrated skin (or ANY skin!) ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 32
[personal] The peptide hype ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 33
Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study ↗
Human study
Original abstract reviewed.
- 34
DermaFrac: An Innovative New Treatment for Periorbital Melanosis in a Dark-Skinned Male Patient ↗
Case report
Full text reviewed.
- 35
A synthetic hexapeptide (Argireline) with antiwrinkle activity ↗
Cell study (Argireline, not SNAP-8)
Original abstract reviewed.
- 36
Plant-based Exosome Injections for Skin Wound Healing: Experimental Study ↗
Animal study (mixture)
Full text reviewed: 18 rats; the injected mixture listed acetyl octapeptide-3 among about 20 ingredients at an unstated amount.
- 37
SNAP-8 (10 mg Vial) Dosage Protocol ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 38
How do you guys formulate Snap-8 for topical use? ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 39
SNAP-8 formulation guidance: dilution and serum concentration help ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 40
Snap8 ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 41
SNAP-8 Dosage question ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 42
Interested in GLOW and Snap 8 but unsure on where to start? ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 43
SNAP-8 (Acetyl Octapeptide-3) Clinical Reference Guide ↗
Protocol guide
Full document reviewed.
Limitation: none of its journal references matched a real SNAP-8 paper in Crossref.
- 44
SNAP-8 Dosage Guide (10mg & 100mg Vials) ↗
Dosing website
Page did not open for us; its dosing text was read from the search-engine copy. Protocol-source claim, not a tested dose.
- 45
SNAP-8 Injection: How to Use, Dosing & What the Evidence Says ↗
Dosing website
Selected original page sections reviewed; protocol-source claim, not a tested dose.
- 46
What's the dosage protocol for snap 8 injection? ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 47
Snap8 ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 48
Snap-8 peptide. ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 49
Adding peptides to serum: Is it really that easy? ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 50
Enhanced Skin Permeation of Anti-wrinkle Peptides via Molecular Modification ↗
Laboratory study (Argireline, not SNAP-8)
Original abstract reviewed.
- 51
ClinicalTrials.gov searches: SNAP-8, acetyl octapeptide, octapeptide-3 ↗
Registry search
Searched through the ClinicalTrials.gov data service: no records for any of the three terms.
- 52
Acetyl Hexapeptide-8 for Blepharospasm, NCT01750346 ↗
Registered study (Argireline, not SNAP-8)
Registry record checked through the ClinicalTrials.gov data service: terminated.
- 53
Method development for acetyl octapeptide-3 analysis by liquid chromatography-tandem mass spectrometry ↗
Laboratory study
Original abstract reviewed.
- 54
Acetyl Octapeptide-3 (product insert, item 27260) ↗
Supplier specification
Full insert reviewed: Ac-EEMQRRAD-NH2, C41H70N16O16S, 1,075.2 g/mol, CAS 868844-74-0; solid stable at least 4 years at −20 °C; aqueous solution not recommended beyond one day.
- 55
The 500 Dalton rule for the skin penetration of chemical compounds and drugs ↗
Review (general skin science)
Original abstract reviewed.
- 56
In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation ↗
Laboratory study (Argireline, not SNAP-8)
Original abstract reviewed.
- 57
Peptide having improved skin permeability and composition comprising same (KR102246906B1) ↗
Patent (fused peptide, not SNAP-8)
Patent text reviewed.
- 58
Snap 8 nasal spray ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 59
Evaluation of topical anti-wrinkle and firming (AWF) for women, anti-wrinkle and firming (AFM) for men and deep wrinkles for wrinkles on face and neck ↗
Human study (uncontrolled)
Full text reviewed; the abstract and body list side effects differently, and this guide uses the body.
- 60
An Open Label Clinical Trial of a Peptide Treatment Serum and Supporting Regimen Designed to Improve the Appearance of Aging Facial Skin ↗
Human study (uncontrolled)
Full text reviewed.
Result detail: participant-rated redness and flaking rose at week 2, when the serum was first added after a two-week run-in on the supporting regimen; redness persisted to week 10 and cleared by week 14; the investigator found no increase, and the abstract reports no adverse events.
- 61
Instrumental and Patient-Reported Assessment of Skin Changes During a 90-Day Dermocosmetic Regimen: A Prospective Single-Arm Observational Study ↗
Human study (uncontrolled)
Original abstract reviewed; the abstract does not list the ingredients, so SNAP-8 content could not be confirmed.
- 62
- 63
DAXXIFY (daxibotulinumtoxinA-lanm) for injection: prescribing information ↗
Label
Label reviewed: indications, mechanism (cleaves SNAP-25), warning on pre-existing neuromuscular disorders, and the RTP004 peptide excipient (35 amino acids).
- 64
A framework for the safety evaluation of peptides in cosmetics ↗
Review
Full text reviewed; lists acetyl octapeptide-3 by class without compound data.
- 65
GHK-CU / Snap-8 topical mixing protocol ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 66
SNAP-8 ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 67
Has anyone tried Snap8? Thoughts? ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 68
GHKcu and SNAP8 Hyaluronic Serum Instructions ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 69
Expression Line Deep Wrinkle Serum (customer reviews) ↗
Community account
Public review page reviewed; seller-hosted reviews may be selected. Reviewer names removed.
- 70
Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (and 503B categories) ↗
Regulatory source
Lists reviewed; no entry for SNAP-8 or acetyl octapeptide-3. Argireline appears, as acetyl hexapeptide-3, in 503B category 3 (nominated without adequate support).
- 71
Cosmetic Ingredient Hotlist: Prohibited and Restricted Ingredients ↗
Regulatory source
Page reviewed for acetyl octapeptide-3, SNAP-8 and related names: none listed.
- 72
Think twice before injecting peptides bought online: unauthorized products can seriously harm you ↗
Regulatory source
Advisory reviewed; SNAP-8 not named.
- 73
Concerns regarding the public health risks associated with unapproved peptide products ↗
Regulatory source
Media release and related alert reviewed from archived copies; SNAP-8 not named.
- 74
- 75
Prohibited List 2027 (in force 1 January 2027) ↗
Regulatory source
Full list reviewed; SNAP-8 not named; category S0 wording checked.
- 76
Snap 8 experiments lets hear them ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 77
Topical GHK-CU and SNAP 8 ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 78
What's your favorite peptide serum to "extend" Botox? ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 79
Snap8 Serum ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 80
Not every Peptide is for You! ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 81
What topical ingredients or products do you guys think are worth it and actually work? ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 82
Best peptide for aging skin. Rebuilding volume. ↗
Community account
Public thread and its comments read from a public archive copy; usernames removed.
- 83
The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study ↗
Human trial (Argireline, not SNAP-8)
Original abstract reviewed.
No matching sources
Try a different term or show the full list.
Updates and corrections
Updated September 26, 2026. Corrected how one protocol page's two strengths are described (separate regimens, not a titration), the strength comparison for misread percentages, one homemade recipe, two study titles and several small study details.
September 24, 2026. This version replaces our earlier SNAP-8 reference page. It adds typical topical protocols with their sources, a strength table that explains the supplier's percentages, the injection schedules websites publish and where their numbers come from, what happens when people stop, storage, monitoring, a comparison with related ingredients, a dated legal-status summary and community experiences. It corrects the earlier page in several places: the human research now covers eight published reports rather than three; the "63%" and "35%" figures are identified as the best single result and the average of one unpublished supplier test; the injection schedule is no longer attributed to a dosing site that has since withdrawn it; and storage advice now comes from the supplier's documents rather than generic peptide pages. The date describes this revision, not a fresh check of every source.
Found an error or a relevant study we missed? Report a correction with the guide title, the specific passage and a supporting source if available. Please leave out personal health records. See our editorial policy for how we handle attribution, evidence limits and corrections.